Literature DB >> 25047914

Amphiphilic bicyclic peptides as cellular delivery agents.

Donghoon Oh1, Shaban Anwar Darwish, Amir Nasrolahi Shirazi, Rakesh Kumar Tiwari, Keykavous Parang.   

Abstract

Two bicyclic peptides composed of tryptophan and arginine residues were synthesized from monocyclic peptide building blocks and evaluated as cellular delivery agents. [W5G]-(triazole)-[KR5] and [W5E]-(β-Ala)-[KR5] containing triazole and β-alanine linkers improved the cellular delivery of fluorescein (F')-labeled phosphopeptide F'-GpYEEI (F'-PP) by 7.6- and 19.3-fold, respectively, in human ovarian adenocarcinoma cells. However, parent monocyclic peptide [R5 ] and monocyclic peptide [WR]4 only enhanced the cellular uptake of the phosphopeptide by only 1.3- and 3.7-fold, respectively. Confocal microscopy showed that the corresponding fluorescein-labeled bicyclic peptide F'-[KW4E]-(β-Ala)-[KR5] was localized in the cytosol and nucleus. Studying the cellular uptake of F'-[KW4E]-(β-Ala)-[KR5] in the presence of endocytosis inhibitors indicated that the clathrin- and caveolin-dependent endocytosis are the main pathways for cellular uptake. The bicyclic peptide was able to improve antiproliferative activity of doxorubicin by 20 %. These data suggest that this bicyclic peptide can be utilized as a new class of cell-penetrating peptides and cellular delivery tools.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  amphiphiles; bicyclic peptides; cell-penetrating; drug delivery; endocytosis

Mesh:

Substances:

Year:  2014        PMID: 25047914     DOI: 10.1002/cmdc.201402230

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  6 in total

1.  Intracellular Delivery of Peptidyl Ligands by Reversible Cyclization: Discovery of a PDZ Domain Inhibitor that Rescues CFTR Activity.

Authors:  Ziqing Qian; Xiaohua Xu; Jeanine F Amacher; Dean R Madden; Estelle Cormet-Boyaka; Dehua Pei
Journal:  Angew Chem Int Ed Engl       Date:  2015-03-17       Impact factor: 15.336

Review 2.  Bicyclic Peptides as Next-Generation Therapeutics.

Authors:  Curran A Rhodes; Dehua Pei
Journal:  Chemistry       Date:  2017-07-27       Impact factor: 5.236

3.  Cyclic peptide-selenium nanoparticles as drug transporters.

Authors:  Amir Nasrolahi Shirazi; Rakesh K Tiwari; Donghoon Oh; Brian Sullivan; Anil Kumar; Yousef A Beni; Keykavous Parang
Journal:  Mol Pharm       Date:  2014-09-17       Impact factor: 4.939

4.  Efficient Intracellular Delivery of Cell-Impermeable Cargo Molecules by Peptides Containing Tryptophan and Histidine.

Authors:  Amir Nasrolahi Shirazi; Saghar Mozaffari; Rinzhin Tshering Sherpa; Rakesh Tiwari; Keykavous Parang
Journal:  Molecules       Date:  2018-06-26       Impact factor: 4.411

5.  The Symmetric Tetravalent Sulfhydryl-Specific Linker NATBA Facilitates a Combinatorial "Tool Kit" Strategy for Phage Display-Based Selection of Functionalized Bicyclic Peptides.

Authors:  Christoph Ernst; Julia Sindlinger; Dirk Schwarzer; Pierre Koch; Frank M Boeckler
Journal:  ACS Omega       Date:  2018-10-01

6.  Switching Between Bicyclic and Linear Peptides - The Sulfhydryl-Specific Linker TPSMB Enables Reversible Cyclization of Peptides.

Authors:  Christoph Ernst; Johannes Heidrich; Catharina Sessler; Julia Sindlinger; Dirk Schwarzer; Pierre Koch; Frank M Boeckler
Journal:  Front Chem       Date:  2018-10-16       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.